TEICOPIN 400 – Trusted Therapy for Serious Gram-Positive Infections.
TEICOPIN 400 – The powerful formulation of Teicoplanin 400 MG Injection delivers targeted bactericidal action against Gram-positive bacterial infections:
Teicoplanin 400 MG Injection is a glycopeptide antibiotic that exerts bactericidal action. It specifically works against gram-positive bacteria, including resistant strains like MRSA and Enterococcus faecalis.
It works by inhibiting the formation of the peptidoglycan layer by binding to D-Ala-D-Ala terminals in the peptidoglycan layer of bacterial cell walls, causing leakage of intracellular components of bacterial cells, leading to cell death. It is effective for managing severe bacterial infections such as respiratory tract infections, urinary tract infections, and skin & soft tissue infections.
Key Benefits of Teicoplanin 400 MG Injection – TEICOPIN 400
✅ Targeted Gram-Positive Coverage – Highly effective against a wide range of Gram-positive pathogens, including MRSA, Enterococci, and Streptococci.
✅ Once Daily Dosing – Its long half-life supports once-daily dosing and makes it ideal for both hospital and home-based treatments.
✅ Superior Safety to Vancomycin – Low nephrotoxicity; compared to Vancomycin, it offers a safer profile in patients with renal impairment, reducing the risk of kidney-related adverse effects.
Recommended By Specialists:
👨⚕️ Critical Care & ICU Specialists: For managing life-threatening infections in immunocompromised patients, where Gram-positive sepsis is suspected.
👨⚕️ Orthopedic Surgeons: For treating bone and joint infections, including osteomyelitis caused by resistant Staphylococci.
👨⚕️ Hematologists & Oncologists: For use in neutropenic patients or those undergoing chemotherapy who are at high risk for bloodstream infections.
👨⚕️ Nephrologists: Preferred in renal-compromised patients due to lower nephrotoxicity compared to Vancomycin.
INDICATIONS:
✅ Urinary Tract Infections
✅ Skin & Soft Tissue Infections
✅ Bloodstream Infections
✅ Bone and Joint Infections
Reviews
There are no reviews yet.